Associated investigators

Associated investigators Inge Jonassen, John Cairns, Ole-Frithjof Norheim, Line Bjørge, Daniela Elena Costea, Camilla Krakstad and Elisabeth Wik.

Updated: 28.11.2019 (First published: 23.04.2014)

Bioinformatics and Big Data

Professor Inge Jonassen and part of his team from the CBU (Computational Bioinformatics Unit, Department of Informatics, UiB) are working on the development and application of bioinformatics methods for analysing data descending from high-throughput measurement technologies applied to cancer samples.

Health Economics

Health economics at CCBIO is concerned with two major research problems: what is the cost-effectiveness of biomarkers, and how does the interplay between the diagnostic market and the pharmaceutical market affect incentives to invest in R&D for cancer biomarkers, termed the industrial...

Global Health Priorities - Ole-Frithjof Norheim

Global Health Priorities is an interdisciplinary research group situated at the Department of Global Health and Primary Care at the University of Bergen. The group consists of a team of cross-disciplinary researchers and professionals dedicated to study the ethics and economics of priority setting...

Line Bjørge

The main research focus of Professor Line Bjørge's group is ovarian cancer, and the aim is to translate data from comprehensive molecular profiling into clinical meaningful strategies to improve prevention and individualized patient care.

Daniela Elena Costea

Professor Daniela Elena Costea and her team in the Experimental Pathology Research Group are focusing on understanding the role of epithelialmesenchymal interactions in carcinoma progression and identification of micro-environment-related prognostic biomarkers.

Camilla Krakstad

Professor Camilla Krakstad has her background from research on signal transduction, and during her PhD she studied cAMP signaling in apoptotic cell death in both normal and cancer cells.

Elisabeth Wik

Dr. Elisabeth Wik has been a member of the Tumor Biology Research Group (directed by Akslen) since 2013, in combination with a position as resident at the Department of Pathology, Haukeland University Hospital. Currently she is also leader of the CCBIO Research School for Cancer Studies.